@article{167be538bd094744b6779b6ce3843aaf,
title = "Effect of seven anti-tuberculosis treatment regimens on sputum microbiome:: a retrospective analysis of the HIGHRIF study 2 and PanACEA MAMS-TB clinical trials",
abstract = "Respiratory tract microbiota has been described as the gatekeeper for respiratory health. We aimed to assess the impact of standard-of-care and experimental anti-tuberculosis treatment regimens on the respiratory microbiome and implications for treatment outcomes.",
author = "Emmanuel Musisi and Adam Wyness and Sahar Eldirdiri and Evelin Dombay and Bariki Mtafya and Ntinginya, \{Nyanda e\} and Norbert Heinrich and Kibiki, \{Gibson s\} and Michael Hoelscher and Martin Boeree and Rob Aarnoutse and Gillespie, \{Stephen h\} and Wilber Sabiiti and Emmanuel Musisi and Bariki Mtafya and Ntinginya, \{Nyanda e.\} and Norbert Heinrich and Kibiki, \{Gibson s.\} and Michael Hoelscher and Martin Boeree and Stephen Gillespie and Wilber Sabiiti and Derek Sloan and Larissa Hoffmann and Ivan Nore{\~n}a and Wandini Lutchmun and Julia Dreisbach and Demel,, \{Petra gross\} and Andrea Kelly and Brake, \{Lindsey te\} and Elin Svensson and Rob Aarnoutse and Isobella Honeyborne and Wildner, \{Leticia muraro\} and Robert Hunt and Mchugh, \{Timothy d.\} and Nunn, \{Andrew j\} and Phillips, \{Patrick p.j.\} and Xue Gong and Rodney Dawson and Kim Narunsky and Andreas Diacon and \{De jager\}, Veronique and Sven Friedrich and Ian Sanne and Mohammed Rassool and Chacha Mangu and Christina Manyama and Issa Sabi and Minja, \{Lilian t.\}",
note = "Copyright {\textcopyright} 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license No accepted date specified.",
year = "2023",
month = nov,
day = "1",
doi = "10.1016/S2666-5247(23)00191-X",
language = "English",
volume = "4",
pages = "e913--e922",
number = "11",
}
SDG 3 Good Health and Well-being